Northern Trust Corp Verastem, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.39 - $0.71 $19,144 - $34,853	49,089 Added 15.94%	356,965 $149,000
Q4 2022 Feb 13, 2023	SELL	$0.33 - $10.44 $233 - $7,381	-707 Reduced 0.23%	307,876 $123,000
Q3 2022 Nov 14, 2022	SELL	$0.92 - $11.16 $977 - $11,851	-1,062 Reduced 0.34%	308,583 $262,000
Q2 2022 Aug 12, 2022	SELL	$1.02 - $1.83 $1.23 Million - $2.21 Million	-1,206,782 Reduced 79.58%	309,645 $359,000
Q1 2022 May 13, 2022	SELL	$1.06 - $2.1 $103,321 - $204,693	-97,473 Reduced 6.04%	1,516,427 $2.14 Million
Q4 2021 Feb 08, 2022	SELL	$2.05 - $3.2 $28,087 - $43,843	-13,701 Reduced 0.84%	1,613,900 $3.31 Million
Q3 2021 Nov 15, 2021	SELL	$2.54 - $4.07 $184,886 - $296,255	-72,790 Reduced 4.28%	1,627,601 $5.01 Million
Q2 2021 Aug 13, 2021	BUY	$2.57 - $4.85 $59,379 - $112,059	23,105 Added 1.38%	1,700,391 $6.92 Million
Q1 2021 May 12, 2021	SELL	$1.9 - $2.82 $239,270 - $355,128	-125,932 Reduced 6.98%	1,677,286 $4.14 Million
Q4 2020 Feb 11, 2021	SELL	$1.15 - $2.4 $37,973 - $79,248	-33,020 Reduced 1.8%	1,803,218 $3.84 Million
Q3 2020 Nov 16, 2020	SELL	$1.11 - $1.68 $65,400 - $98,983	-58,919 Reduced 3.11%	1,836,238 $2.22 Million
Q2 2020 Aug 14, 2020	BUY	$1.69 - $4.2 $2.74 Million - $6.8 Million	1,619,872 Added 588.43%	1,895,157 $3.26 Million
Q1 2020 May 14, 2020	BUY	$1.26 - $3.38 $167,065 - $448,160	132,592 Added 92.92%	275,285 $727,000
Q4 2019 Feb 14, 2020	SELL	$0.86 - $1.44 $7,188 - $12,036	-8,359 Reduced 5.53%	142,693 $191,000
Q3 2019 Nov 13, 2019	SELL	$1.21 - $1.59 $703,065 - $923,863	-581,046 Reduced 79.37%	151,052 $183,000
Q2 2019 Aug 13, 2019	SELL	$1.25 - $3.14 $98,825 - $248,248	-79,060 Reduced 9.75%	732,098 $1.11 Million
Q1 2019 May 13, 2019	SELL	$2.79 - $4.09 $38,437 - $56,347	-13,777 Reduced 1.67%	811,158 $2.4 Million
Q4 2018 Feb 12, 2019	SELL	$3.23 - $7.01 $66,735 - $144,833	-20,661 Reduced 2.44%	824,935 $2.77 Million
Q3 2018 Nov 14, 2018	BUY	$6.86 - $9.97 $1.51 Million - $2.2 Million	220,438 Added 35.26%	845,596 $6.13 Million
Q2 2018 Sep 18, 2018	BUY	$2.88 - $8.67 $81,590 - $245,621	28,330 Added 4.75%	625,158 $4.3 Million
Q2 2018 Aug 14, 2018	BUY	$2.88 - $8.67 $1.45 Million - $4.35 Million	501,836 Added 528.29%	596,828 $4.11 Million
Q1 2018 May 09, 2018	BUY	$2.92 - $3.81 $83,141 - $108,482	28,473 Added 42.8%	94,992 $284,000
Q3 2017 Nov 13, 2017	BUY	$3.01 - $5.41 $200,222 - $359,867	66,519	66,519 $313,000

Others Institutions Holding VSTM

# of Institutions

Shares Held

297K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

225K
Shares

$1.05 Million
0.14% of portfolio
Beaumont Financial Partners, LLC

48K
Shares

$224,640
0.0% of portfolio
Eaton Vance Management Boston, MA

20K
Shares

$93,600
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.99K
Shares

$13,969
0.0% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.07K
Shares

$5,026
0.0% of portfolio

View Full List

About Verastem, Inc.

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $983M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

More about VSTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account